Surge in Put Option Trading Highlights Bearish Outlook
On 24 April 2026, Cipla Ltd (NSE: CIPLA) emerged as the most active stock in put options, with 4,516 contracts traded at the ₹1,260 strike price expiring on 28 April 2026. This volume translated into a turnover of ₹1.92 crores, underscoring robust investor interest in downside protection or speculative bearish bets. The open interest at this strike stands at 1,213 contracts, indicating sustained positioning rather than transient trading.
The underlying stock price closed at ₹1,286.5, just above the put strike, suggesting that traders are positioning for a potential decline below this level in the near term. This activity is particularly noteworthy given Cipla’s status as a large-cap pharmaceutical stock with a market capitalisation of ₹1,05,484 crores.
Price Action and Technical Context
Cipla’s share price has recently shown signs of weakness after a three-day rally, with a 1.46% decline on the day, underperforming its sector by 0.61% and the Sensex by 0.75%. The stock touched an intraday low of ₹1,254.1, a 3.97% drop from recent highs, with heavier volume traded near this low point, signalling selling pressure.
Technically, Cipla’s price remains above its 5-day, 20-day, and 50-day moving averages but below the longer-term 100-day and 200-day averages. This mixed moving average alignment suggests a consolidation phase with potential downside risk if the stock fails to reclaim the longer-term averages.
Investor participation has also increased markedly, with delivery volumes rising 70.52% to 22.33 lakh shares on 23 April compared to the five-day average. This heightened activity may reflect both fresh short positions and hedging by long holders amid uncertainty.
Mojo Score and Analyst Sentiment
Cipla’s current Mojo Score stands at 41.0, categorised as a Sell, a downgrade from Hold on 7 January 2026. This rating shift reflects deteriorating fundamentals or technical signals, reinforcing the cautious stance among market participants. The downgrade aligns with the increased put option interest, suggesting that professional analysts and traders alike are factoring in downside risks.
Expiry Patterns and Implications for Investors
The expiry date of 28 April 2026 is critical, as options expiry often triggers volatility and price discovery. The concentration of put options at ₹1,260 indicates a key support level that traders are watching closely. Should the stock breach this strike decisively, it could trigger further downside momentum, potentially attracting more put buying or short selling.
Conversely, if Cipla manages to hold above this level, the put option activity may represent hedging by long investors rather than outright bearish speculation. The open interest data will be crucial to monitor in the coming days to discern whether positions are being unwound or added.
Sector and Market Context
The Pharmaceuticals & Biotechnology sector has been under pressure recently, with Cipla’s 1-day sector return at -0.90% and the broader Sensex down 0.71%. Cipla’s underperformance relative to its sector and the benchmark index highlights company-specific challenges or profit-taking after recent gains.
Given Cipla’s large-cap status and liquidity profile—capable of handling trade sizes up to ₹6.63 crores based on recent average traded value—the stock remains a focal point for institutional investors managing portfolio risk through options strategies.
Investor Takeaways and Strategic Considerations
For investors, the heavy put option activity at the ₹1,260 strike price ahead of expiry suggests a cautious approach is warranted. Those holding Cipla shares might consider protective puts to hedge against further downside, while traders could explore bearish strategies if technical support breaks.
Long-term investors should monitor the stock’s ability to sustain above its 100-day and 200-day moving averages, which will be key indicators of trend direction. Meanwhile, the increased delivery volumes and open interest in puts highlight a market environment where volatility and directional uncertainty are elevated.
Overall, Cipla’s current market signals point to a phase of consolidation with a bearish tilt, making it imperative for investors to stay vigilant and adjust positions accordingly as expiry approaches.
